secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001093557-26-000003
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dexcom Q4 revenue $1.26B beats high end; FY2026 outlook $5.16-5.25B; new CEO Jake Leach
--------------------------------------------------------------------------------

- Q4 total revenue ~$1.260B (+13% YoY), US $892M (+11%), Intl $368M (+18%).
- FY2025 revenue ~$4.662B (+16%); reiterates non-GAAP gross margin ~61%, operating margin 20-21%.
- FY2026 revenue guidance $5.16-5.25B (+11-13%); non-GAAP gross margin 63-64%, operating margin 22-23%.
- Jake Leach assumed CEO role Jan 1, 2026, succeeding Kevin Sayer; presents at JPM conference.
- Stelo app reimagined with AI; G7 15 Day system shipping to pharmacies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355726000003/0001093557-26-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355726000003/dxcm-20260107.htm
  HTML page:      https://secwatch.observer/filing/0001093557-26-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer